Please login to the form below

Not currently logged in


This page shows the latest patents news and features for those working in and with pharma, biotech and healthcare.

US start-up EQRx promises approach that will slash drug prices

US start-up EQRx promises approach that will slash drug prices

Armed with a healthy $200m in Series A funding, EQRx intends to create “novel, patent-protected medicines at prices that are more affordable for people and sustainable for healthcare systems”, according

Latest news

More from news
Approximately 68 fully matching, plus 1,575 partially matching documents found.

Latest Intelligence

  • The mission matters The mission matters

    Through reimbursement, patent protection and research funding, most modern societies encourage and enable pharmaceutical and medical technology companies to profit from human illness and injury.

  • The Golden Goose The Golden Goose

    For example, Trump abandoned plans to outlaw rebates, forbade shortening drug patents in the new version of the NAFTA treaty and sought to weaken a 1980 law known as Bayh-Dole

  • Changing direction: adapting to a rapidly-evolving environment Changing direction: adapting to a rapidly-evolving environment

    At the same time, therapeutic advances and disruptive technology have brought new competition to established players, while the loss of patents for some of the world’s most successful medicines has

  • Building European biotech firms to rival those of the US Building European biotech firms to rival those of the US

    Some great academic research is still being published before patents have been filed, or too much information being given away, including to other academics. ... Universities can help academics get a bit smarter about this – if academics do have plans

  • Trust: the ultimate elevator Trust: the ultimate elevator

    This is particularly apparent for the traditional ‘big pharma’ sector – shaken by scandals such as pricing, manipulative patent litigation and a rampant opioid epidemic.

More from intelligence
Approximately 2 fully matching, plus 119 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Making a difference with patient support

    This is just one example of how together, Bedrock and Origins deliver truly patent-centric PSPs.

  • Apex launches Lumentium UK demo experience to pharma market

    Lumentium was created by a team in Madrid. The team has secured worldwide patents on its TableMapping technology.

  • Three strategies for managing loss of exclusivity successfully

    Patent losses could sink Allergan”. “Drug prices to plummet in wave of expiring patents”. ... patent cliff” is an ominous prospect for drug manufacturers – shrouded in the threat of job losses and falling share prices.

  • Cello Health Acquire ISS Cello Health Acquire ISS

    The technical service offering includes consultancy at all stages in the regulatory process, support of FDA Advisory Committee meetings, and data provision in legal defence of patent and intellectual property

  • 03 Health Services

    How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation. ... The pharma market is about to get busy. 2011–2013 marks a patent cliff, when many big-selling drugs went, or soon will go, off patent.

More from PMHub
Approximately 1 fully matching, plus 39 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...